Causes of Elevated Mean Platelet Volume (MPV)

Primary Causes

• Elevated Mean Platelet Volume (MPV) is primarily caused by conditions that involve increased platelet turnover or destruction, myeloproliferative disorders, and certain inflammatory or metabolic conditions 1
• Myeloproliferative disorders, including essential thrombocythemia, polycythemia vera, primary myelofibrosis, and chronic myeloid leukemia, are major causes of elevated MPV 2
• Platelet destruction conditions, such as immune thrombocytopenia (ITP) and disseminated intravascular coagulation (DIC), consistently show elevated MPV values 2

Secondary Causes

• Hematologic disorders, including post-hemorrhagic states, hemolytic anemia, post-splenectomy or functional hyposplenism, and rebound thrombocytosis after treatment of thrombocytopenia, can cause elevated MPV 2
• Stroke is a cardiovascular condition that can cause elevated MPV 2

Physiological Causes

• Pregnancy and hormonal influences can cause temporary elevation in MPV 2
• Exercise-induced changes may transiently increase MPV 2
• Aging is associated with gradually increasing MPV values 1

Clinical Significance and Monitoring

• Serial measurements of MPV are more valuable than isolated readings to establish chronicity and monitor disease progression 1
• In patients with myeloproliferative disorders like polycythemia vera, monitoring MPV alongside other parameters helps assess disease activity and thrombotic risk 3, 1

Important Caveats

• Pre-analytical variables, such as time between blood collection and analysis, can significantly affect MPV measurement 2
• In conditions with increased hematocrit, standard amounts of anticoagulant with reduced plasma volume can affect platelet parameters 2

Elevated Mean Platelet Volume Causes and Associations

Myeloproliferative Disorders

• In polycythemia vera, platelet abnormalities including altered size occur alongside qualitative platelet defects such as abnormal activation and altered glycoprotein expression, as noted by the Mayo Clinic Proceedings 4, 5
• These disorders show defective TPO clearance due to reduced c-mpl membrane expression, leading to inappropriately normal or elevated TPO levels despite increased platelet mass, according to the Mayo Clinic Proceedings 6

Bleeding Risk Assessment

• Monitoring for bleeding risk in patients with very high MPV and thrombocytopenia is necessary, as acquired von Willebrand disease may occur in myeloproliferative disorders like polycythemia vera, as referenced by the Mayo Clinic Proceedings 4